|
1
|
Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond.
|
Circulation
|
2010
|
13.28
|
|
2
|
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
J Am Coll Cardiol
|
2013
|
11.88
|
|
3
|
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.
|
Circulation
|
2013
|
10.07
|
|
4
|
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute.
|
Circulation
|
2006
|
8.01
|
|
5
|
Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure.
|
JAMA
|
2010
|
6.91
|
|
6
|
Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).
|
Am Heart J
|
2005
|
6.34
|
|
7
|
Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke.
|
JAMA
|
2013
|
5.05
|
|
8
|
Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association.
|
Circ Heart Fail
|
2013
|
4.98
|
|
9
|
Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure.
|
JAMA
|
2007
|
4.89
|
|
10
|
Epidemiology and risk profile of heart failure.
|
Nat Rev Cardiol
|
2010
|
4.88
|
|
11
|
Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure.
|
JAMA
|
2006
|
4.30
|
|
12
|
Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database.
|
J Am Coll Cardiol
|
2005
|
4.26
|
|
13
|
Get With the Guidelines-Stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attack.
|
Circulation
|
2008
|
4.00
|
|
14
|
2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.
|
Circulation
|
2013
|
3.86
|
|
15
|
Linking inpatient clinical registry data to Medicare claims data using indirect identifiers.
|
Am Heart J
|
2009
|
3.57
|
|
16
|
Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group.
|
Circulation
|
2008
|
3.56
|
|
17
|
Digoxin reduces 30-day all-cause hospital admission in older patients with chronic systolic heart failure.
|
Am J Med
|
2013
|
3.46
|
|
18
|
Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis.
|
Circulation
|
2009
|
3.43
|
|
19
|
Cardiorenal interactions: insights from the ESCAPE trial.
|
J Am Coll Cardiol
|
2008
|
3.35
|
|
20
|
State of the art: using natriuretic peptide levels in clinical practice.
|
Eur J Heart Fail
|
2008
|
3.35
|
|
21
|
Body mass index and mortality in heart failure: a meta-analysis.
|
Am Heart J
|
2008
|
3.25
|
|
22
|
Rehospitalization for heart failure: problems and perspectives.
|
J Am Coll Cardiol
|
2012
|
3.24
|
|
23
|
Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure.
|
J Am Coll Cardiol
|
2004
|
3.08
|
|
24
|
Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator.
|
JAMA
|
2012
|
3.07
|
|
25
|
Use of aldosterone antagonists in heart failure.
|
JAMA
|
2009
|
3.00
|
|
26
|
Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure.
|
J Am Coll Cardiol
|
2002
|
2.97
|
|
27
|
Is hospital admission for heart failure really necessary?: the role of the emergency department and observation unit in preventing hospitalization and rehospitalization.
|
J Am Coll Cardiol
|
2013
|
2.89
|
|
28
|
Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention.
|
J Am Coll Cardiol
|
2010
|
2.86
|
|
29
|
Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry.
|
Eur Heart J
|
2007
|
2.80
|
|
30
|
High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database.
|
J Card Fail
|
2007
|
2.75
|
|
31
|
The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL.
|
J Lipid Res
|
2004
|
2.72
|
|
32
|
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
|
J Am Coll Cardiol
|
2005
|
2.71
|
|
33
|
Predictors of adherence to performance measures in patients with acute myocardial infarction.
|
Am J Med
|
2012
|
2.64
|
|
34
|
Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine.
|
Eur J Heart Fail
|
2010
|
2.64
|
|
35
|
Relation of loop diuretic dose to mortality in advanced heart failure.
|
Am J Cardiol
|
2006
|
2.59
|
|
36
|
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute.
|
J Am Coll Cardiol
|
2006
|
2.57
|
|
37
|
Racial and ethnic differences in the treatment of acute myocardial infarction: findings from the Get With the Guidelines-Coronary Artery Disease program.
|
Circulation
|
2010
|
2.53
|
|
38
|
An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention.
|
J Am Coll Cardiol
|
2013
|
2.47
|
|
39
|
Cardiac troponin and outcome in acute heart failure.
|
N Engl J Med
|
2008
|
2.41
|
|
40
|
Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
|
J Am Coll Cardiol
|
2008
|
2.39
|
|
41
|
Race/ethnicity, quality of care, and outcomes in ischemic stroke.
|
Circulation
|
2010
|
2.32
|
|
42
|
Associations between aldosterone antagonist therapy and risks of mortality and readmission among patients with heart failure and reduced ejection fraction.
|
JAMA
|
2012
|
2.25
|
|
43
|
Sex differences in medical care and early death after acute myocardial infarction.
|
Circulation
|
2008
|
2.17
|
|
44
|
Need for increased awareness and evidence-based therapies for patients hospitalized for heart failure.
|
JAMA
|
2013
|
2.17
|
|
45
|
Four-variable risk model in men and women with heart failure.
|
Circ Heart Fail
|
2013
|
2.14
|
|
46
|
Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry.
|
J Am Coll Cardiol
|
2009
|
2.14
|
|
47
|
Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations.
|
Am J Cardiol
|
2005
|
2.11
|
|
48
|
An unexpected inverse relationship between HbA1c levels and mortality in patients with diabetes and advanced systolic heart failure.
|
Am Heart J
|
2006
|
2.11
|
|
49
|
Visual assessment of brain magnetic resonance imaging detects injury to cognitive regulatory sites in patients with heart failure.
|
J Card Fail
|
2013
|
2.07
|
|
50
|
Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines.
|
Am Heart J
|
2008
|
2.06
|
|
51
|
Racial and survival paradoxes in chronic kidney disease.
|
Nat Clin Pract Nephrol
|
2007
|
2.06
|
|
52
|
B-type natriuretic peptide level and postdischarge thrombotic events in older patients hospitalized with heart failure: insights from the Acute Decompensated Heart Failure National Registry.
|
Am Heart J
|
2012
|
2.04
|
|
53
|
Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes.
|
Circulation
|
2012
|
2.03
|
|
54
|
Relationship of race/ethnicity with door-to-balloon time and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: findings from Get With the Guidelines-Coronary Artery Disease.
|
Clin Cardiol
|
2013
|
2.02
|
|
55
|
Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial.
|
Eur Heart J
|
2013
|
1.99
|
|
56
|
Discharge to a skilled nursing facility and subsequent clinical outcomes among older patients hospitalized for heart failure.
|
Circ Heart Fail
|
2011
|
1.99
|
|
57
|
Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial.
|
Arch Intern Med
|
2007
|
1.98
|
|
58
|
Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
|
Am Heart J
|
2008
|
1.97
|
|
59
|
An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention.
|
Hypertension
|
2013
|
1.95
|
|
60
|
Clinical effectiveness of implantable cardioverter-defibrillators among medicare beneficiaries with heart failure.
|
Circ Heart Fail
|
2009
|
1.95
|
|
61
|
Changes in myocardial infarction guideline adherence as a function of patient risk: an end to paradoxical care?
|
J Am Coll Cardiol
|
2011
|
1.92
|
|
62
|
Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure.
|
Circulation
|
2003
|
1.90
|
|
63
|
Waist circumference, body mass index, and survival in systolic heart failure: the obesity paradox revisited.
|
J Card Fail
|
2011
|
1.90
|
|
64
|
The obesity paradox in the elderly: potential mechanisms and clinical implications.
|
Clin Geriatr Med
|
2009
|
1.89
|
|
65
|
Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry.
|
J Am Coll Cardiol
|
2009
|
1.88
|
|
66
|
A call to ACTION (acute coronary treatment and intervention outcomes network): a national effort to promote timely clinical feedback and support continuous quality improvement for acute myocardial infarction.
|
Circ Cardiovasc Qual Outcomes
|
2009
|
1.86
|
|
67
|
Use of cardiac resynchronization therapy in patients hospitalized with heart failure.
|
Circulation
|
2008
|
1.81
|
|
68
|
Quality of care for atrial fibrillation among patients hospitalized for heart failure.
|
J Am Coll Cardiol
|
2009
|
1.81
|
|
69
|
Use of two recipient lists for adults requiring heart transplantation.
|
J Thorac Cardiovasc Surg
|
2003
|
1.78
|
|
70
|
Strategies used by hospitals to improve speed of tissue-type plasminogen activator treatment in acute ischemic stroke.
|
Stroke
|
2014
|
1.76
|
|
71
|
Outcomes registry for better informed treatment of atrial fibrillation: rationale and design of ORBIT-AF.
|
Am Heart J
|
2011
|
1.72
|
|
72
|
Metformin therapy and outcomes in patients with advanced systolic heart failure and diabetes.
|
J Card Fail
|
2009
|
1.70
|
|
73
|
Association of patient case-mix adjustment, hospital process performance rankings, and eligibility for financial incentives.
|
JAMA
|
2008
|
1.69
|
|
74
|
Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials.
|
J Am Coll Cardiol
|
2003
|
1.67
|
|
75
|
The NCDR ACTION Registry-GWTG: transforming contemporary acute myocardial infarction clinical care.
|
Heart
|
2010
|
1.67
|
|
76
|
Regional brain gray matter loss in heart failure.
|
J Appl Physiol (1985)
|
2003
|
1.67
|
|
77
|
Risk score for in-hospital ischemic stroke mortality derived and validated within the Get With the Guidelines-Stroke Program.
|
Circulation
|
2010
|
1.66
|
|
78
|
American Heart Association Guide for Improving Cardiovascular Health at the Community Level, 2013 update: a scientific statement for public health practitioners, healthcare providers, and health policy makers.
|
Circulation
|
2013
|
1.66
|
|
79
|
Temporal trends and predictors in the use of aldosterone antagonists post-acute myocardial infarction.
|
J Am Coll Cardiol
|
2012
|
1.65
|
|
80
|
2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.
|
Circulation
|
2016
|
1.65
|
|
81
|
Payment source, quality of care, and outcomes in patients hospitalized with heart failure.
|
J Am Coll Cardiol
|
2011
|
1.65
|
|
82
|
Relationship between clinical trial site enrollment with participant characteristics, protocol completion, and outcomes: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) trial.
|
J Am Coll Cardiol
|
2012
|
1.64
|
|
83
|
2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.
|
Circulation
|
2014
|
1.64
|
|
84
|
Association between direct measures of body composition and prognostic factors in chronic heart failure.
|
Mayo Clin Proc
|
2010
|
1.63
|
|
85
|
Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry.
|
Circulation
|
2013
|
1.63
|
|
86
|
The paradox of dysfunctional high-density lipoprotein.
|
Curr Opin Lipidol
|
2007
|
1.63
|
|
87
|
Incremental value of clinical data beyond claims data in predicting 30-day outcomes after heart failure hospitalization.
|
Circ Cardiovasc Qual Outcomes
|
2010
|
1.63
|
|
88
|
Process of care performance measures and long-term outcomes in patients hospitalized with heart failure.
|
Med Care
|
2010
|
1.62
|
|
89
|
Mode and mechanisms of death after orthotopic heart transplantation.
|
Heart Rhythm
|
2009
|
1.60
|
|
90
|
Outcomes in mild or rapidly improving stroke not treated with intravenous recombinant tissue-type plasminogen activator: findings from Get With The Guidelines-Stroke.
|
Stroke
|
2011
|
1.60
|
|
91
|
ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines.
|
J Am Coll Cardiol
|
2014
|
1.58
|
|
92
|
National efforts to improve door-to-balloon time results from the Door-to-Balloon Alliance.
|
J Am Coll Cardiol
|
2009
|
1.57
|
|
93
|
Factors associated with improvement in ejection fraction in clinical practice among patients with heart failure: findings from IMPROVE HF.
|
Am Heart J
|
2012
|
1.57
|
|
94
|
Impairment of activities of daily living and incident heart failure in community-dwelling older adults.
|
Eur J Heart Fail
|
2012
|
1.54
|
|
95
|
Emergency medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke.
|
Circ Cardiovasc Qual Outcomes
|
2012
|
1.54
|
|
96
|
Evidence of clinical practice heterogeneity in the use of implantable cardioverter-defibrillators in heart failure and post-myocardial infarction left ventricular dysfunction: Findings from IMPROVE HF.
|
Heart Rhythm
|
2009
|
1.53
|
|
97
|
In-hospital major bleeding during ST-elevation and non-ST-elevation myocardial infarction care: derivation and validation of a model from the ACTION Registry®-GWTG™.
|
Am J Cardiol
|
2011
|
1.53
|
|
98
|
Global and regional putamen volume loss in patients with heart failure.
|
Eur J Heart Fail
|
2011
|
1.52
|
|
99
|
An organized approach to improvement in guideline adherence for acute myocardial infarction: results with the Get With The Guidelines quality improvement program.
|
Arch Intern Med
|
2008
|
1.52
|
|
100
|
Characterization of heart failure patients with preserved ejection fraction: a comparison between ADHERE-US registry and ADHERE-International registry.
|
Eur J Heart Fail
|
2011
|
1.51
|
|
101
|
The "golden hour" and acute brain ischemia: presenting features and lytic therapy in >30,000 patients arriving within 60 minutes of stroke onset.
|
Stroke
|
2010
|
1.50
|
|
102
|
Utilization of hospice and predicted mortality risk among older patients hospitalized with heart failure: findings from GWTG-HF.
|
J Card Fail
|
2012
|
1.50
|
|
103
|
The relationship between body mass index, treatment, and mortality in patients with established coronary artery disease: a report from APPROACH.
|
Eur Heart J
|
2009
|
1.48
|
|
104
|
Albumin levels predict survival in patients with systolic heart failure.
|
Am Heart J
|
2008
|
1.48
|
|
105
|
Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial.
|
Eur Heart J
|
2013
|
1.47
|
|
106
|
ACCF/AHA consensus conference report on professionalism and ethics.
|
Circulation
|
2004
|
1.47
|
|
107
|
Systematic review of the incidence of sudden cardiac death in the United States.
|
J Am Coll Cardiol
|
2011
|
1.47
|
|
108
|
2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.
|
J Thorac Cardiovasc Surg
|
2014
|
1.44
|
|
109
|
Troponin elevation in heart failure prevalence, mechanisms, and clinical implications.
|
J Am Coll Cardiol
|
2010
|
1.43
|
|
110
|
Outpatient cardiology practices with advanced practice nurses and physician assistants provide similar delivery of recommended therapies (findings from IMPROVE HF).
|
Am J Cardiol
|
2010
|
1.43
|
|
111
|
Medical therapies and invasive treatments for coronary artery disease by body mass: the "obesity paradox" in the Get With The Guidelines database.
|
Am J Cardiol
|
2007
|
1.43
|
|
112
|
2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards).
|
J Am Coll Cardiol
|
2014
|
1.43
|
|
113
|
High-density lipoprotein function recent advances.
|
J Am Coll Cardiol
|
2005
|
1.42
|
|
114
|
Risk score for intracranial hemorrhage in patients with acute ischemic stroke treated with intravenous tissue-type plasminogen activator.
|
Stroke
|
2012
|
1.41
|
|
115
|
Muscle mechanoreceptor sensitivity in heart failure.
|
Am J Physiol Heart Circ Physiol
|
2004
|
1.41
|
|
116
|
B-type natriuretic peptide levels in obese patients with advanced heart failure.
|
J Am Coll Cardiol
|
2005
|
1.41
|
|
117
|
Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure.
|
J Am Coll Cardiol
|
2004
|
1.41
|
|
118
|
Brain injury in autonomic, emotional, and cognitive regulatory areas in patients with heart failure.
|
J Card Fail
|
2008
|
1.41
|
|
119
|
Representativeness of a national heart failure quality-of-care registry: comparison of OPTIMIZE-HF and non-OPTIMIZE-HF Medicare patients.
|
Circ Cardiovasc Qual Outcomes
|
2009
|
1.41
|
|
120
|
2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards).
|
J Nucl Cardiol
|
2015
|
1.41
|
|
121
|
Clinical assessment of acute heart failure syndromes: emergency department through the early post-discharge period.
|
Heart
|
2011
|
1.41
|
|
122
|
Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
|
Am Heart J
|
2007
|
1.40
|
|
123
|
Predictors of cardiac rehabilitation referral in coronary artery disease patients: findings from the American Heart Association's Get With The Guidelines Program.
|
J Am Coll Cardiol
|
2009
|
1.40
|
|
124
|
Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure.
|
J Card Fail
|
2002
|
1.40
|
|
125
|
Genetic basis of atherosclerosis: part I: new genes and pathways.
|
Circulation
|
2004
|
1.40
|
|
126
|
Quality of care in women with ischemic stroke in the GWTG program.
|
Stroke
|
2009
|
1.39
|
|
127
|
Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia.
|
Circulation
|
2008
|
1.39
|
|
128
|
Impact of time of presentation on the care and outcomes of acute myocardial infarction.
|
Circulation
|
2008
|
1.39
|
|
129
|
Risk adjustment for in-hospital mortality of contemporary patients with acute myocardial infarction: the acute coronary treatment and intervention outcomes network (ACTION) registry-get with the guidelines (GWTG) acute myocardial infarction mortality model and risk score.
|
Am Heart J
|
2011
|
1.39
|
|
130
|
Targeting myocardial substrate metabolism in heart failure: potential for new therapies.
|
Eur J Heart Fail
|
2012
|
1.36
|
|
131
|
Glucose, obesity, metabolic syndrome, and diabetes relevance to incidence of heart failure.
|
J Am Coll Cardiol
|
2010
|
1.36
|
|
132
|
Development of stroke performance measures: definitions, methods, and current measures.
|
Stroke
|
2010
|
1.34
|
|
133
|
Weekend hospital admission and discharge for heart failure: association with quality of care and clinical outcomes.
|
Am Heart J
|
2009
|
1.34
|
|
134
|
Trends in use of implantable cardioverter-defibrillator therapy among patients hospitalized for heart failure: have the previously observed sex and racial disparities changed over time?
|
Circulation
|
2012
|
1.34
|
|
135
|
A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach.
|
Eur Heart J
|
2008
|
1.33
|
|
136
|
A validated risk score for in-hospital mortality in patients with heart failure from the American Heart Association get with the guidelines program.
|
Circ Cardiovasc Qual Outcomes
|
2009
|
1.32
|
|
137
|
Incident heart failure hospitalization and subsequent mortality in chronic heart failure: a propensity-matched study.
|
J Card Fail
|
2008
|
1.32
|
|
138
|
Clinical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE-HF.
|
Eur J Heart Fail
|
2012
|
1.31
|
|
139
|
Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals.
|
Circ Cardiovasc Qual Outcomes
|
2013
|
1.31
|
|
140
|
Representativeness of the Get With The Guidelines-Stroke Registry: comparison of patient and hospital characteristics among Medicare beneficiaries hospitalized with ischemic stroke.
|
Stroke
|
2011
|
1.31
|
|
141
|
Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial.
|
Eur Heart J
|
2013
|
1.30
|
|
142
|
Prevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic peptide levels in heart failure with preserved ejection fraction.
|
Am J Cardiol
|
2012
|
1.28
|
|
143
|
Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction.
|
J Am Coll Cardiol
|
2004
|
1.28
|
|
144
|
Achieving rapid reperfusion with primary percutaneous coronary intervention remains a challenge: insights from American Heart Association's Get With the Guidelines program.
|
Am Heart J
|
2008
|
1.27
|
|
145
|
Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward.
|
Circ Heart Fail
|
2010
|
1.27
|
|
146
|
Pathophysiologic targets in the early phase of acute heart failure syndromes.
|
Am J Cardiol
|
2005
|
1.27
|
|
147
|
2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.
|
J Am Coll Cardiol
|
2016
|
1.24
|
|
148
|
Admission, discharge, or change in B-type natriuretic peptide and long-term outcomes: data from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) linked to Medicare claims.
|
Circ Heart Fail
|
2011
|
1.24
|
|
149
|
Characteristics and outcomes in African American patients with decompensated heart failure.
|
Arch Intern Med
|
2008
|
1.22
|
|
150
|
Door-to-balloon times in hospitals within the get-with-the-guidelines registry after initiation of the door-to-balloon (D2B) Alliance.
|
Am J Cardiol
|
2009
|
1.22
|
|
151
|
Renin-angiotensin inhibition in systolic heart failure and chronic kidney disease.
|
Am J Med
|
2012
|
1.22
|
|
152
|
Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial.
|
JAMA
|
2013
|
1.21
|
|
153
|
Racial and ethnic differences in outcomes in older patients with acute ischemic stroke.
|
Circ Cardiovasc Qual Outcomes
|
2013
|
1.20
|
|
154
|
Emotional well-being of heart failure patients and their caregivers.
|
J Card Fail
|
2002
|
1.20
|
|
155
|
2013 ACCF/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes and coronary artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Acute Coronary Syndromes and Coronary Artery Disease Clinical Data Standards).
|
Circulation
|
2013
|
1.19
|
|
156
|
ACCF/AHA 2011 key data elements and definitions of a base cardiovascular vocabulary for electronic health records: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards.
|
J Am Coll Cardiol
|
2011
|
1.19
|
|
157
|
2013 ACCF/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes and coronary artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on clinical data standards (writing committee to develop acute coronary syndromes and coronary artery disease clinical data standards).
|
J Am Coll Cardiol
|
2013
|
1.19
|
|
158
|
Improved treatment of hospitalized coronary artery disease patients with the get with the guidelines program.
|
Crit Pathw Cardiol
|
2007
|
1.18
|
|
159
|
Effects of a home-based exercise program on clinical outcomes in heart failure.
|
Am Heart J
|
2007
|
1.18
|
|
160
|
Brain axonal and myelin evaluation in heart failure.
|
J Neurol Sci
|
2011
|
1.18
|
|
161
|
Patterns of emergency medical services use and its association with timely stroke treatment: findings from Get With the Guidelines-Stroke.
|
Circ Cardiovasc Qual Outcomes
|
2013
|
1.17
|
|
162
|
Early withdrawal of statin therapy in patients with non-ST-segment elevation myocardial infarction: national registry of myocardial infarction.
|
Arch Intern Med
|
2004
|
1.17
|
|
163
|
Home monitoring for heart failure management.
|
J Am Coll Cardiol
|
2012
|
1.17
|
|
164
|
Risk-standardizing survival for in-hospital cardiac arrest to facilitate hospital comparisons.
|
J Am Coll Cardiol
|
2013
|
1.17
|
|
165
|
Baseline characteristics, quality of care, and outcomes of younger and older Medicare beneficiaries hospitalized with heart failure: findings from the Alabama Heart Failure Project.
|
Int J Cardiol
|
2011
|
1.17
|
|
166
|
2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.
|
J Am Coll Cardiol
|
2014
|
1.16
|
|
167
|
Gender differences in in-hospital management and outcomes in patients with decompensated heart failure: analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
|
J Card Fail
|
2006
|
1.16
|
|
168
|
Get With The Guidelines program participation, process of care, and outcome for Medicare patients hospitalized with heart failure.
|
Circ Cardiovasc Qual Outcomes
|
2012
|
1.15
|
|
169
|
Early adoption of dabigatran and its dosing in US patients with atrial fibrillation: results from the outcomes registry for better informed treatment of atrial fibrillation.
|
J Am Heart Assoc
|
2013
|
1.15
|
|
170
|
National survey of hospital strategies to reduce heart failure readmissions: findings from the Get With the Guidelines-Heart Failure registry.
|
Circ Heart Fail
|
2012
|
1.15
|
|
171
|
Hospital certification for optimizing cardiovascular disease and stroke quality of care and outcomes.
|
Circulation
|
2010
|
1.15
|
|
172
|
Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failure.
|
Am Heart J
|
2005
|
1.14
|
|
173
|
Data quality in the American Heart Association Get With The Guidelines-Stroke (GWTG-Stroke): results from a national data validation audit.
|
Am Heart J
|
2012
|
1.14
|
|
174
|
Dietary sodium intake in heart failure.
|
Circulation
|
2012
|
1.14
|
|
175
|
The American Heart Association's recommendations for expanding the applications of existing and future clinical registries: a policy statement from the American Heart Association.
|
Circulation
|
2011
|
1.14
|
|
176
|
High platelet count as a link between renal cachexia and cardiovascular mortality in end-stage renal disease patients.
|
Am J Clin Nutr
|
2011
|
1.13
|
|
177
|
Epidemiology of dialysis patients and heart failure patients.
|
Semin Nephrol
|
2006
|
1.13
|
|
178
|
Compliance behaviors of elderly patients with advanced heart failure.
|
J Cardiovasc Nurs
|
2003
|
1.13
|
|
179
|
Association of race/ethnicity with clinical risk factors, quality of care, and acute outcomes in patients hospitalized with heart failure.
|
Am Heart J
|
2011
|
1.13
|
|
180
|
Times from symptom onset to hospital arrival in the Get with the Guidelines--Stroke Program 2002 to 2009: temporal trends and implications.
|
Stroke
|
2012
|
1.12
|
|
181
|
Mammillary bodies and fornix fibers are injured in heart failure.
|
Neurobiol Dis
|
2008
|
1.12
|
|
182
|
Temporal trends in treatment and outcomes for advanced heart failure with reduced ejection fraction from 1993-2010: findings from a university referral center.
|
Circ Heart Fail
|
2013
|
1.12
|
|
183
|
Differential prognostic effect of systolic blood pressure on mortality according to left-ventricular function in patients with acute heart failure.
|
Eur J Heart Fail
|
2010
|
1.12
|
|
184
|
Quality of care and outcomes among patients with heart failure and chronic kidney disease: A Get With the Guidelines -- Heart Failure Program study.
|
Am Heart J
|
2008
|
1.12
|
|
185
|
Modest increase in peak VO2 is related to better clinical outcomes in chronic heart failure patients: results from heart failure and a controlled trial to investigate outcomes of exercise training.
|
Circ Heart Fail
|
2012
|
1.12
|
|
186
|
ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines.
|
Circulation
|
2014
|
1.12
|
|
187
|
Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
|
Crit Pathw Cardiol
|
2009
|
1.11
|
|
188
|
Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF.
|
Am Heart J
|
2009
|
1.11
|
|
189
|
Trends in the use of evidence-based treatments for coronary artery disease among women and the elderly: findings from the get with the guidelines quality-improvement program.
|
Circ Cardiovasc Qual Outcomes
|
2009
|
1.10
|
|
190
|
High-density lipoprotein: is it always atheroprotective?
|
Curr Atheroscler Rep
|
2006
|
1.10
|
|
191
|
Depression and clinical outcomes in heart failure: an OPTIMIZE-HF analysis.
|
Am J Med
|
2009
|
1.09
|
|
192
|
Electronic health records and quality of care for heart failure.
|
Am Heart J
|
2010
|
1.09
|
|
193
|
Impact of early initiation of intravenous therapy for acute decompensated heart failure on outcomes in ADHERE.
|
Cardiology
|
2006
|
1.09
|
|
194
|
Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis.
|
J Am Coll Cardiol
|
2008
|
1.09
|
|
195
|
Atherosclerosis secondary prevention performance measures after coronary bypass graft surgery compared with percutaneous catheter intervention and nonintervention patients in the Get With the Guidelines database.
|
Circulation
|
2007
|
1.09
|
|
196
|
Quality of care and outcomes in patients with diabetes hospitalized with ischemic stroke: findings from Get With the Guidelines-Stroke.
|
Stroke
|
2010
|
1.08
|
|
197
|
Genetic basis of atherosclerosis: part II: clinical implications.
|
Circulation
|
2004
|
1.08
|
|
198
|
Micronutrient deficiencies an unmet need in heart failure.
|
J Am Coll Cardiol
|
2009
|
1.08
|
|
199
|
Optimal blood pressure levels in patients with coronary artery disease.
|
J Am Coll Cardiol
|
2006
|
1.08
|
|
200
|
Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry).
|
Am J Cardiol
|
2008
|
1.07
|
|
201
|
Characteristics and in-hospital outcomes for nonadherent patients with heart failure: findings from Get With The Guidelines-Heart Failure (GWTG-HF).
|
Am Heart J
|
2009
|
1.07
|
|
202
|
Renin-Angiotensin system antagonists and mortality in patients with heart failure.
|
JAMA
|
2013
|
1.07
|
|
203
|
Angiotensin receptor blockers and outcomes in real-world older patients with heart failure and preserved ejection fraction: a propensity-matched inception cohort clinical effectiveness study.
|
Eur J Heart Fail
|
2012
|
1.07
|
|
204
|
Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States.
|
J Am Heart Assoc
|
2014
|
1.06
|
|
205
|
Relationships between emerging measures of heart failure processes of care and clinical outcomes.
|
Am Heart J
|
2010
|
1.06
|
|
206
|
ACCF/AHA/AMA-PCPI 2011 performance measures for adults with heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement.
|
J Am Coll Cardiol
|
2012
|
1.06
|
|
207
|
Rationale and design of the multicentre, randomized, double-blind, placebo-controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT).
|
Eur J Heart Fail
|
2010
|
1.06
|
|
208
|
Functional abnormalities in brain areas that mediate autonomic nervous system control in advanced heart failure.
|
J Card Fail
|
2005
|
1.05
|
|
209
|
Comment on "the relationship between the C-statistic of a risk-adjustment model and the accuracy of hospital report cards: a Monte Carlo study".
|
Med Care
|
2013
|
1.05
|
|
210
|
Are registry hospitals different? A comparison of patients admitted to hospitals of a commercial heart failure registry with those from national and community cohorts.
|
Am Heart J
|
2006
|
1.05
|
|
211
|
Reverse epidemiology beyond dialysis patients: chronic heart failure, geriatrics, rheumatoid arthritis, COPD, and AIDS.
|
Semin Dial
|
2007
|
1.05
|
|
212
|
Uncontrolled hypertension and increased risk for incident heart failure in older adults with hypertension: findings from a propensity-matched prospective population study.
|
J Am Soc Hypertens
|
2010
|
1.04
|
|
213
|
A risk score for in-hospital death in patients admitted with ischemic or hemorrhagic stroke.
|
J Am Heart Assoc
|
2013
|
1.04
|
|
214
|
Quality of care of and outcomes for African Americans hospitalized with heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) registry.
|
J Am Coll Cardiol
|
2008
|
1.04
|
|
215
|
Reduced body weight and adiposity with a high-protein diet improves functional status, lipid profiles, glycemic control, and quality of life in patients with heart failure: a feasibility study.
|
J Cardiovasc Nurs
|
2009
|
1.03
|
|
216
|
Hospital performance recognition with the Get With The Guidelines Program and mortality for acute myocardial infarction and heart failure.
|
Am Heart J
|
2009
|
1.03
|
|
217
|
Trends in death attributed to heart failure over the past two decades in Europe.
|
Eur J Heart Fail
|
2012
|
1.03
|
|
218
|
Transitional adherence and persistence in the use of aldosterone antagonist therapy in patients with heart failure.
|
Am Heart J
|
2013
|
1.03
|
|
219
|
Cognitive test performance and brain pathology.
|
Nurs Res
|
2008
|
1.03
|
|
220
|
Characteristics of patients hospitalized with acute decompensated heart failure who are referred for hospice care.
|
Arch Intern Med
|
2007
|
1.03
|
|
221
|
Renin-angiotensin inhibition in diastolic heart failure and chronic kidney disease.
|
Am J Med
|
2013
|
1.03
|
|
222
|
Strategies and opportunities for drug development in heart failure.
|
JAMA
|
2013
|
1.03
|
|
223
|
Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions.
|
Heart Fail Rev
|
2014
|
1.03
|
|
224
|
Cachexia: common, deadly, with an urgent need for precise definition and new therapies.
|
Am J Cardiol
|
2008
|
1.02
|
|
225
|
Acute heart failure syndromes: clinical scenarios and pathophysiologic targets for therapy.
|
Heart Fail Rev
|
2007
|
1.02
|
|
226
|
Association of hospital primary angioplasty volume in ST-segment elevation myocardial infarction with quality and outcomes.
|
JAMA
|
2009
|
1.02
|
|
227
|
Preventing tomorrow's sudden cardiac death today: dissemination of effective therapies for sudden cardiac death prevention.
|
Am Heart J
|
2008
|
1.01
|
|
228
|
Generalizability and longitudinal outcomes of a national heart failure clinical registry: Comparison of Acute Decompensated Heart Failure National Registry (ADHERE) and non-ADHERE Medicare beneficiaries.
|
Am Heart J
|
2010
|
1.01
|
|
229
|
Heart failure disease management programs: a cost-effectiveness analysis.
|
Am Heart J
|
2007
|
1.01
|
|
230
|
Heart failure disease management programs: not a class effect.
|
Circulation
|
2004
|
1.01
|
|
231
|
Trends in clinical, demographic, and biochemical characteristics of patients with acute myocardial infarction from 2003 to 2008: a report from the american heart association get with the guidelines coronary artery disease program.
|
J Am Heart Assoc
|
2012
|
1.01
|
|
232
|
Presence of atrial fibrillation is independently associated with adverse outcomes in patients hospitalized with heart failure: an analysis of get with the guidelines-heart failure.
|
Circ Heart Fail
|
2012
|
1.01
|
|
233
|
Differential mortality association of loop diuretic dosage according to blood urea nitrogen and carbohydrate antigen 125 following a hospitalization for acute heart failure.
|
Eur J Heart Fail
|
2012
|
1.01
|
|
234
|
Nutritional and anti-inflammatory interventions in chronic heart failure.
|
Am J Cardiol
|
2008
|
1.01
|
|
235
|
Do countries or hospitals with longer hospital stays for acute heart failure have lower readmission rates?: Findings from ASCEND-HF.
|
Circ Heart Fail
|
2013
|
1.00
|
|
236
|
Quality of care and in-hospital outcomes in patients with coronary heart disease in rural and urban hospitals (from Get With the Guidelines-Coronary Artery Disease Program).
|
Am J Cardiol
|
2009
|
0.99
|
|
237
|
Influence of age on the management of heart failure: findings from Get With the Guidelines-Heart Failure (GWTG-HF).
|
Am Heart J
|
2009
|
0.99
|
|
238
|
Are quality improvements in the get with the guidelines: stroke program related to better care or better data documentation?
|
Circ Cardiovasc Qual Outcomes
|
2011
|
0.98
|
|
239
|
Recent nationwide trends in discharge statin treatment of hospitalized patients with stroke.
|
Stroke
|
2010
|
0.98
|
|
240
|
Phase III clinical trial end points in acute heart failure syndromes: a virtual roundtable with the Acute Heart Failure Syndromes International Working Group.
|
Am Heart J
|
2009
|
0.98
|
|
241
|
Care and outcomes of Hispanic patients admitted with heart failure with preserved or reduced ejection fraction: findings from get with the guidelines-heart failure.
|
Circ Heart Fail
|
2012
|
0.97
|
|
242
|
Stroke quality metrics: systematic reviews of the relationships to patient-centered outcomes and impact of public reporting.
|
Stroke
|
2011
|
0.97
|
|
243
|
The dissociation between door-to-balloon time improvement and improvements in other acute myocardial infarction care processes and patient outcomes.
|
Arch Intern Med
|
2009
|
0.97
|
|
244
|
Translating research into practice for healthcare providers: the American Heart Association's strategy for building healthier lives, free of cardiovascular diseases and stroke.
|
Circulation
|
2008
|
0.97
|
|
245
|
Predicting costs among medicare beneficiaries with heart failure.
|
Am J Cardiol
|
2011
|
0.96
|
|
246
|
2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards).
|
Circulation
|
2014
|
0.96
|
|
247
|
Age and gender differences in quality of care and outcomes for patients with ST-segment elevation myocardial infarction.
|
Am J Med
|
2012
|
0.96
|
|
248
|
Isolated diastolic hypotension and incident heart failure in older adults.
|
Hypertension
|
2011
|
0.96
|
|
249
|
Quality indicators for the care of heart failure in vulnerable elders.
|
J Am Geriatr Soc
|
2007
|
0.96
|
|
250
|
QRS duration, bundle-branch block morphology, and outcomes among older patients with heart failure receiving cardiac resynchronization therapy.
|
JAMA
|
2013
|
0.96
|
|
251
|
Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF.
|
Circ Heart Fail
|
2010
|
0.96
|
|
252
|
Are quality improvements associated with the Get With the Guidelines-Coronary Artery Disease (GWTG-CAD) program sustained over time? A longitudinal comparison of GWTG-CAD hospitals versus non-GWTG-CAD hospitals.
|
Am Heart J
|
2010
|
0.95
|
|
253
|
Influence of coronary artery disease and coronary revascularization status on outcomes in patients with acute heart failure syndromes: a report from OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure).
|
Eur J Heart Fail
|
2008
|
0.95
|
|
254
|
Cholesterol levels and in-hospital mortality in patients with acute decompensated heart failure.
|
Am Heart J
|
2008
|
0.95
|
|
255
|
Illicit stimulant use in a United States heart failure population presenting to the emergency department (from the Acute Decompensated Heart Failure National Registry Emergency Module).
|
Am J Cardiol
|
2008
|
0.95
|
|
256
|
Associations between worsening renal function and 30-day outcomes among Medicare beneficiaries hospitalized with heart failure.
|
Am Heart J
|
2010
|
0.95
|
|
257
|
Acute heart failure syndromes in patients with coronary artery disease early assessment and treatment.
|
J Am Coll Cardiol
|
2009
|
0.95
|
|
258
|
Cardiorenal syndrome: pathophysiology and potential targets for clinical management.
|
Nat Rev Nephrol
|
2012
|
0.95
|
|
259
|
Aberrant central nervous system responses to the Valsalva maneuver in heart failure.
|
Congest Heart Fail
|
2007
|
0.95
|
|
260
|
ACCF/AHA 2011 key data elements and definitions of a base cardiovascular vocabulary for electronic health records: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards.
|
Circulation
|
2011
|
0.95
|
|
261
|
Acupuncture inhibits sympathetic activation during mental stress in advanced heart failure patients.
|
J Card Fail
|
2002
|
0.94
|
|
262
|
Racial differences in the prevalence and outcomes of atrial fibrillation among patients hospitalized with heart failure.
|
J Am Heart Assoc
|
2013
|
0.94
|
|
263
|
Long-term outcomes of medicare beneficiaries with worsening renal function during hospitalization for heart failure.
|
Am J Cardiol
|
2010
|
0.94
|
|
264
|
Coronary artery disease, coronary revascularization, and outcomes in chronic advanced systolic heart failure.
|
Int J Cardiol
|
2010
|
0.94
|
|
265
|
A qualitative assessment of practices associated with shorter door-to-needle time for thrombolytic therapy in acute ischemic stroke.
|
J Neurosci Nurs
|
2011
|
0.94
|
|
266
|
Adherence to guideline-recommended adjunctive heart failure therapies among outpatient cardiology practices (findings from IMPROVE HF).
|
Am J Cardiol
|
2010
|
0.94
|
|
267
|
The need for multiple measures of hospital quality: results from the Get with the Guidelines-Heart Failure Registry of the American Heart Association.
|
Circulation
|
2011
|
0.94
|
|
268
|
Temporal trends in gastrointestinal bleeding associated with percutaneous coronary intervention: analysis of the 1998-2006 Nationwide Inpatient Sample (NIS) database.
|
Am Heart J
|
2011
|
0.94
|
|
269
|
Quality of care and outcomes among patients with acute myocardial infarction by level of kidney function at admission: report from the get with the guidelines coronary artery disease program.
|
Clin Cardiol
|
2012
|
0.93
|
|
270
|
Translating evidence into practice: a decade of efforts by the American Heart Association/American Stroke Association to reduce death and disability due to stroke: a presidential advisory from the American Heart Association/American Stroke Association.
|
Stroke
|
2010
|
0.93
|
|
271
|
Care and outcomes of Asian-American acute myocardial infarction patients: findings from the American Heart Association Get With The Guidelines-Coronary Artery Disease program.
|
Circ Cardiovasc Qual Outcomes
|
2012
|
0.93
|
|
272
|
Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: an analysis of 65,396 hospitalizations from 344 hospitals participating in Get With The Guidelines (GWTG).
|
Am Heart J
|
2010
|
0.93
|
|
273
|
Anticoagulation in heart failure: current status and future direction.
|
Heart Fail Rev
|
2013
|
0.93
|
|
274
|
Quality of care for acute coronary syndrome patients with known atherosclerotic disease: results from the Get With the Guidelines Program.
|
Circulation
|
2009
|
0.93
|
|
275
|
Use of aldosterone antagonists at discharge after myocardial infarction: results from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network (ACTION) Registry-Get with the Guidelines (GWTG).
|
Am Heart J
|
2013
|
0.93
|
|
276
|
Guideline adherence after ST-segment elevation versus non-ST segment elevation myocardial infarction.
|
Circ Cardiovasc Qual Outcomes
|
2012
|
0.93
|
|
277
|
In-hospital initiation of statins: taking advantage of the 'teachable moment'.
|
Cleve Clin J Med
|
2003
|
0.93
|
|
278
|
Hypoalbuminaemia and incident heart failure in older adults.
|
Eur J Heart Fail
|
2011
|
0.93
|
|
279
|
Obesity paradox as a component of reverse epidemiology in heart failure.
|
Arch Intern Med
|
2005
|
0.93
|
|
280
|
Effect of serum insulin on the association between hyperuricemia and incident heart failure.
|
Am J Cardiol
|
2010
|
0.92
|
|
281
|
Is exercise adherence associated with clinical outcomes in patients with advanced heart failure?
|
Phys Sportsmed
|
2010
|
0.92
|
|
282
|
Predictors of hospital length of stay in heart failure: findings from Get With the Guidelines.
|
J Card Fail
|
2011
|
0.92
|
|
283
|
Validity of pedometers for measuring exercise adherence in heart failure patients.
|
J Card Fail
|
2005
|
0.92
|
|
284
|
Angiotensin-converting enzyme inhibitors and outcomes in heart failure and preserved ejection fraction.
|
Am J Med
|
2013
|
0.92
|
|
285
|
Patterns and predictors of evidence-based medication continuation among hospitalized heart failure patients (from Get With the Guidelines-Heart Failure).
|
Am J Cardiol
|
2011
|
0.92
|
|
286
|
Prediabetes is not an independent risk factor for incident heart failure, other cardiovascular events or mortality in older adults: findings from a population-based cohort study.
|
Int J Cardiol
|
2013
|
0.91
|
|
287
|
Stroke outcomes measures must be appropriately risk adjusted to ensure quality care of patients: a presidential advisory from the American Heart Association/American Stroke Association.
|
Stroke
|
2014
|
0.91
|
|
288
|
The safety of intravenous diuretics alone versus diuretics plus parenteral vasoactive therapies in hospitalized patients with acutely decompensated heart failure: a propensity score and instrumental variable analysis using the Acutely Decompensated Heart Failure National Registry (ADHERE) database.
|
Am Heart J
|
2007
|
0.91
|
|
289
|
Society of Chest Pain Centers Recommendations for the evaluation and management of the observation stay acute heart failure patient: a report from the Society of Chest Pain Centers Acute Heart Failure Committee.
|
Crit Pathw Cardiol
|
2008
|
0.91
|
|
290
|
Tipping the scale: heart failure, body mass index, and prognosis.
|
Circulation
|
2007
|
0.91
|
|
291
|
Association of insurance status with inpatient treatment for coronary artery disease: findings from the Get With the Guidelines program.
|
Am Heart J
|
2010
|
0.91
|
|
292
|
Trends in acute kidney injury and outcomes after early percutaneous coronary intervention in patients ≥75 years of age with acute myocardial infarction.
|
Am J Cardiol
|
2013
|
0.90
|
|
293
|
Treatment and risk in heart failure: gaps in evidence or quality?
|
Circ Cardiovasc Qual Outcomes
|
2010
|
0.90
|
|
294
|
Quality of care and outcomes for in-hospital ischemic stroke: findings from the National Get With The Guidelines-Stroke.
|
Stroke
|
2013
|
0.90
|
|
295
|
Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure.
|
Heart Fail Rev
|
2013
|
0.90
|
|
296
|
Synthesizing lessons learned from get with the guidelines: the value of disease-based registries in improving quality and outcomes.
|
Circulation
|
2013
|
0.90
|
|
297
|
Association of beta-blocker use and selectivity with outcomes in patients with heart failure and chronic obstructive pulmonary disease (from OPTIMIZE-HF).
|
Am J Cardiol
|
2012
|
0.90
|
|
298
|
Incremental cost-effectiveness of guideline-directed medical therapies for heart failure.
|
J Am Coll Cardiol
|
2013
|
0.90
|
|
299
|
Paradoxical association of smoking with in-hospital mortality among patients admitted with acute ischemic stroke.
|
J Am Heart Assoc
|
2013
|
0.90
|
|
300
|
Azygos vein lead implantation: a novel adjunctive technique for implantable cardioverter defibrillator placement.
|
J Cardiovasc Electrophysiol
|
2004
|
0.90
|
|
301
|
Evidence-Based Policy Making: Assessment of the American Heart Association's Strategic Policy Portfolio: A Policy Statement From the American Heart Association.
|
Circulation
|
2016
|
0.90
|
|
302
|
Weighting components of composite end points in clinical trials: an approach using disability-adjusted life-years.
|
Stroke
|
2011
|
0.89
|
|
303
|
Sex differences in in-hospital mortality in acute decompensated heart failure with reduced and preserved ejection fraction.
|
Am Heart J
|
2012
|
0.89
|
|
304
|
Ultrafiltration in heart failure with cardiorenal syndrome.
|
N Engl J Med
|
2013
|
0.89
|
|
305
|
2012 ACCF/AHA/ACR/SCAI/SIR/STS/SVM/SVN/SVS key data elements and definitions for peripheral atherosclerotic vascular disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Peripheral Atherosclerotic Vascular Disease).
|
Circulation
|
2011
|
0.89
|
|
306
|
ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
J Am Coll Cardiol
|
2012
|
0.89
|
|
307
|
Patient and hospital characteristics associated with traditional measures of inpatient quality of care for patients with heart failure.
|
Am Heart J
|
2012
|
0.89
|
|
308
|
ACC/AHA 2013 methodology for developing clinical data standards: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards.
|
J Am Coll Cardiol
|
2013
|
0.88
|
|
309
|
Anti-inflammatory properties of HDL.
|
Rev Endocr Metab Disord
|
2004
|
0.88
|
|
310
|
Medication dosing in outpatients with heart failure after implementation of a practice-based performance improvement intervention: findings from IMPROVE HF.
|
Congest Heart Fail
|
2011
|
0.88
|
|
311
|
Regional differences in quality of care and outcomes for the treatment of acute coronary syndromes: an analysis from the get with the guidelines coronary artery disease program.
|
Crit Pathw Cardiol
|
2010
|
0.88
|
|
312
|
Early vasoactive drugs improve heart failure outcomes.
|
Congest Heart Fail
|
2009
|
0.88
|
|
313
|
Use of tissue-type plasminogen activator before and after publication of the European Cooperative Acute Stroke Study III in Get With The Guidelines-Stroke.
|
Circ Cardiovasc Qual Outcomes
|
2012
|
0.88
|
|
314
|
Review of current and investigational pharmacologic agents for acute heart failure syndromes.
|
Am J Cardiol
|
2006
|
0.88
|
|
315
|
The importance of consistent, high-quality acute myocardial infarction and heart failure care results from the American Heart Association's Get with the Guidelines Program.
|
J Am Coll Cardiol
|
2011
|
0.88
|
|
316
|
Lack of association between electronic health record systems and improvement in use of evidence-based heart failure therapies in outpatient cardiology practices.
|
Clin Cardiol
|
2012
|
0.88
|
|
317
|
Dysphagia screening and hospital-acquired pneumonia in patients with acute ischemic stroke: findings from Get with the Guidelines--Stroke.
|
J Stroke Cerebrovasc Dis
|
2013
|
0.88
|
|
318
|
Society of Chest Pain Centers recommendations for the evaluation and management of the observation stay acute heart failure patient-parts 1-6.
|
Acute Card Care
|
2009
|
0.88
|
|
319
|
Patterns, predictors, variations, and temporal trends in emergency medical service hospital prenotification for acute ischemic stroke.
|
J Am Heart Assoc
|
2012
|
0.88
|
|
320
|
Rate-control versus rhythm-control strategies and outcomes in septuagenarians with atrial fibrillation.
|
Am J Med
|
2013
|
0.87
|
|
321
|
The relationship between body mass index and cardiopulmonary exercise testing in chronic systolic heart failure.
|
Am Heart J
|
2009
|
0.87
|
|
322
|
Outcomes associated with warfarin use in older patients with heart failure and atrial fibrillation and a cardiovascular implantable electronic device: findings from the ADHERE registry linked to Medicare claims.
|
Clin Cardiol
|
2012
|
0.87
|
|
323
|
Comparative effectiveness research in heart failure therapies: women, elderly patients, and patients with kidney disease.
|
Heart Fail Clin
|
2012
|
0.87
|
|
324
|
Impact of obesity on quality of life and depression in patients with heart failure.
|
Eur J Heart Fail
|
2006
|
0.87
|
|
325
|
Improvement in risk stratification with the combination of the tumour marker antigen carbohydrate 125 and brain natriuretic peptide in patients with acute heart failure.
|
Eur Heart J
|
2010
|
0.87
|
|
326
|
Cyclooxygenase products sensitize muscle mechanoreceptors in humans with heart failure.
|
Am J Physiol Heart Circ Physiol
|
2008
|
0.87
|
|
327
|
Interleukin-6 (IL-6) expression and natural killer (NK) cell dysfunction and anergy in heart failure.
|
Am J Cardiol
|
2004
|
0.87
|
|
328
|
Representativeness of RELAX-AHF clinical trial population in acute heart failure.
|
Circ Cardiovasc Qual Outcomes
|
2014
|
0.87
|
|
329
|
Heart failure management in skilled nursing facilities: a scientific statement from the American Heart Association and the Heart Failure Society of America.
|
Circ Heart Fail
|
2015
|
0.87
|
|
330
|
Rate versus rhythm control for management of atrial fibrillation in clinical practice: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
|
Am Heart J
|
2013
|
0.86
|
|
331
|
Frequency and determinants of lipid testing in ischemic stroke and transient ischemic attack: findings from get with the guidelines-stroke.
|
Stroke
|
2009
|
0.86
|
|
332
|
Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study.
|
Eur J Heart Fail
|
2012
|
0.86
|
|
333
|
Use of evidence-based cardiac prevention therapy among outpatients with atrial fibrillation.
|
Am J Med
|
2013
|
0.86
|
|
334
|
Congestion is an important diagnostic and therapeutic target in heart failure.
|
Rev Cardiovasc Med
|
2006
|
0.86
|
|
335
|
Usefulness of a home-based exercise program for overweight and obese patients with advanced heart failure.
|
Am J Cardiol
|
2006
|
0.86
|
|
336
|
Recent trends in early outcome of adult patients after heart transplantation: a single-institution review of 251 transplants using standard donor organs.
|
Am J Transplant
|
2002
|
0.86
|
|
337
|
Cardiac resynchronization therapy utilization for heart failure: findings from IMPROVE HF.
|
Am Heart J
|
2009
|
0.86
|
|
338
|
Design and rationale of studies of neurohormonal blockade and outcomes in diastolic heart failure using OPTIMIZE-HF registry linked to Medicare data.
|
Int J Cardiol
|
2011
|
0.86
|
|
339
|
Associations of patient demographic characteristics and regional physician density with early physician follow-up among medicare beneficiaries hospitalized with heart failure.
|
Am J Cardiol
|
2011
|
0.86
|
|
340
|
Modifying the anti-inflammatory effects of high-density lipoprotein.
|
Curr Atheroscler Rep
|
2007
|
0.86
|
|
341
|
Death and rehospitalization after transient ischemic attack or acute ischemic stroke: one-year outcomes from the adherence evaluation of acute ischemic stroke-longitudinal registry.
|
J Stroke Cerebrovasc Dis
|
2012
|
0.86
|
|
342
|
Improvement in use of anticoagulation therapy in patients with ischemic stroke: results from Get With The Guidelines-Stroke.
|
Am Heart J
|
2011
|
0.85
|
|
343
|
Differential use of warfarin for secondary stroke prevention in patients with various types of atrial fibrillation.
|
Am J Cardiol
|
2008
|
0.85
|
|
344
|
Comparisons of guideline-recommended therapies in patients with documented coronary artery disease having percutaneous coronary intervention versus coronary artery bypass grafting versus medical therapy only (from the REACH International Registry).
|
Am J Cardiol
|
2007
|
0.85
|
|
345
|
Influence of hospital length of stay for heart failure on quality of care.
|
Am J Cardiol
|
2008
|
0.85
|
|
346
|
Risk stratification in women enrolled in the Acute Decompensated Heart Failure National Registry Emergency Module (ADHERE-EM).
|
Acad Emerg Med
|
2008
|
0.85
|
|
347
|
Reinforcing a continuum of care: in-hospital initiation of long-term secondary prevention following acute coronary syndromes.
|
Cardiovasc Drugs Ther
|
2007
|
0.85
|
|
348
|
Prognostic significance of serum total cholesterol and triglyceride levels in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial).
|
Am J Cardiol
|
2012
|
0.85
|
|
349
|
Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF.
|
Circ Heart Fail
|
2013
|
0.84
|
|
350
|
Impaired cerebellar and limbic responses to the valsalva maneuver in heart failure.
|
Cerebellum
|
2012
|
0.84
|
|
351
|
Prevention of heart failure in older adults may require higher levels of physical activity than needed for other cardiovascular events.
|
Int J Cardiol
|
2013
|
0.84
|
|
352
|
Regional differences in clinical profile, quality of care, and outcomes among Hispanic patients hospitalized with acute myocardial infarction in the Get with Guidelines-Coronary Artery Disease (GWTG-CAD) registry.
|
Am Heart J
|
2011
|
0.84
|
|
353
|
Equitable improvement for women and men in the use of guideline-recommended therapies for heart failure: findings from IMPROVE HF.
|
J Card Fail
|
2010
|
0.84
|
|
354
|
Comparison of usefulness of each of five predictors of mortality and urgent transplantation in patients with advanced heart failure.
|
Am J Cardiol
|
2010
|
0.84
|
|
355
|
Predictors of delivery of hospital-based heart failure patient education: a report from OPTIMIZE-HF.
|
J Card Fail
|
2007
|
0.84
|
|
356
|
Reduced treatment success in lipid management among women with coronary heart disease or risk equivalents: results of a national survey.
|
Am Heart J
|
2006
|
0.84
|
|
357
|
Assessing stroke patients for rehabilitation during the acute hospitalization: findings from the get with the guidelines-stroke program.
|
Arch Phys Med Rehabil
|
2012
|
0.84
|
|
358
|
Influence of renal function on the use of guideline-recommended therapies for patients with heart failure.
|
Am J Cardiol
|
2010
|
0.84
|
|
359
|
Trends in smoking cessation counseling: experience from American Heart Association-get with the guidelines.
|
Clin Cardiol
|
2012
|
0.84
|
|
360
|
Factors associated with discharge lipid-lowering drug prescription in patients hospitalized for coronary artery disease (from the Get With the Guidelines database).
|
Am J Cardiol
|
2008
|
0.83
|
|
361
|
Relation of systolic blood pressure to survival in both ischemic and nonischemic systolic heart failure.
|
Am J Cardiol
|
2008
|
0.83
|
|
362
|
Statins do not significantly affect muscle sympathetic nerve activity in humans with nonischemic heart failure: a double-blind placebo-controlled trial.
|
J Card Fail
|
2011
|
0.83
|
|
363
|
Management of post-myocardial infarction patients with left ventricular systolic dysfunction.
|
Am J Med
|
2007
|
0.83
|
|
364
|
Pharmacologic prophylaxis for venous thromboembolism and 30-day outcomes among older patients hospitalized with heart failure: an analysis from the ADHERE national registry linked to Medicare claims.
|
Clin Cardiol
|
2011
|
0.83
|
|
365
|
Abnormalities of calcium handling proteins in skeletal muscle mirror those of the heart in humans with heart failure: a shared mechanism?
|
J Card Fail
|
2012
|
0.83
|
|
366
|
Implementing critical pathways and a multidisciplinary team approach to cardiovascular disease management.
|
Am J Cardiol
|
2008
|
0.83
|
|
367
|
Impact of reduced kidney function on cardiopulmonary fitness in patients with systolic heart failure.
|
Am J Nephrol
|
2010
|
0.83
|
|
368
|
Soluble guanylate cyclase: a potential therapeutic target for heart failure.
|
Heart Fail Rev
|
2013
|
0.83
|
|
369
|
hsCRP and HDL effects of statins trial (CHEST): rapid effect of statin therapy on C-reactive protein and high-density lipoprotein levels A clinical investigation.
|
Heart Dis
|
2003
|
0.83
|
|
370
|
Quality of acute myocardial infarction care and outcomes in 33,997 patients aged 80 years or older: findings from Get With The Guidelines-Coronary Artery Disease (GWTG-CAD).
|
Am Heart J
|
2011
|
0.83
|
|
371
|
Concomitant diabetes mellitus and heart failure.
|
Curr Probl Cardiol
|
2014
|
0.83
|
|
372
|
Pro-HEART - a randomized clinical trial to test the effectiveness of a high protein diet targeting obese individuals with heart failure: rationale, design and baseline characteristics.
|
Contemp Clin Trials
|
2013
|
0.83
|
|
373
|
Two-year follow-up of quality of life in patients referred for heart transplant.
|
Heart Lung
|
2005
|
0.83
|
|
374
|
Hospital variation in intravenous inotrope use for patients hospitalized with heart failure: insights from Get With The Guidelines.
|
Circ Heart Fail
|
2014
|
0.83
|
|
375
|
Task force 3: Disclosure of relationships with commercial interests: policy for educational activities and publications.
|
J Am Coll Cardiol
|
2004
|
0.83
|
|
376
|
Admission heart rate and in-hospital outcomes in patients hospitalized for heart failure in sinus rhythm and in atrial fibrillation.
|
Am Heart J
|
2013
|
0.82
|
|
377
|
Effect of warfarin on outcomes in septuagenarian patients with atrial fibrillation.
|
Am J Cardiol
|
2011
|
0.82
|
|
378
|
Global variation in quality of care among patients hospitalized with acute heart failure in an international trial: findings from the acute study clinical effectiveness of nesiritide in decompensated heart failure trial (ASCEND-HF).
|
Circ Cardiovasc Qual Outcomes
|
2013
|
0.82
|
|
379
|
Early intravenous heart failure therapy and outcomes among older patients hospitalized for acute decompensated heart failure: findings from the Acute Decompensated Heart Failure Registry Emergency Module (ADHERE-EM).
|
Am Heart J
|
2013
|
0.82
|
|
380
|
Early management of patients with acute heart failure: state of the art and future directions--a consensus document from the SAEM/HFSA acute heart failure working group.
|
Acad Emerg Med
|
2014
|
0.82
|
|
381
|
Workplace wellness recognition for optimizing workplace health: a presidential advisory from the American Heart Association.
|
Circulation
|
2015
|
0.82
|
|
382
|
ACC/AHA/AACVPR/AAFP/ANA concepts for clinician-patient shared accountability in performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.
|
Circulation
|
2014
|
0.82
|
|
383
|
The relationship between body mass index and mortality in patients hospitalized with acute decompensated heart failure.
|
Am Heart J
|
2007
|
0.82
|
|
384
|
The impact of obesity on survival in patients with heart failure.
|
Heart Fail Monit
|
2002
|
0.82
|
|
385
|
patient and practice factors associated with improvement in use of guideline-recommended therapies for outpatients with heart failure (from the IMPROVE HF trial).
|
Am J Cardiol
|
2011
|
0.82
|
|
386
|
A propensity-matched study of the association of diabetes mellitus with incident heart failure and mortality among community-dwelling older adults.
|
Am J Cardiol
|
2011
|
0.82
|
|
387
|
Comparative effectiveness of cardiac resynchronization therapy with an implantable cardioverter-defibrillator versus defibrillator therapy alone: a cohort study.
|
Ann Intern Med
|
2014
|
0.82
|
|
388
|
Relationship between sex, ejection fraction, and B-type natriuretic peptide levels in patients hospitalized with heart failure and associations with inhospital outcomes: findings from the Get With The Guideline-Heart Failure Registry.
|
Am Heart J
|
2013
|
0.82
|
|
389
|
2013 ACCF/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes and coronary artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Acute Coronary Syndromes and Coronary Artery Disease Clinical Data Standards).
|
Crit Pathw Cardiol
|
2013
|
0.82
|
|
390
|
Cardiac resynchronization therapy response is associated with shorter duration of atrial fibrillation.
|
Pacing Clin Electrophysiol
|
2007
|
0.82
|
|
391
|
Thrombolysis 3 to 4.5 hours after acute ischemic stroke.
|
N Engl J Med
|
2008
|
0.82
|
|
392
|
Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: An analysis of 65,396 hospitalizations from 344 hospita participating in Get With The Guidelines (GWTG).
|
Am Heart J
|
2011
|
0.82
|
|
393
|
Orthostatic hypotension and incident heart failure in community-dwelling older adults.
|
J Gerontol A Biol Sci Med Sci
|
2013
|
0.82
|
|
394
|
Influence of dedicated heart failure clinics on delivery of recommended therapies in outpatient cardiology practices: findings from the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF).
|
Am Heart J
|
2010
|
0.81
|
|
395
|
Association between smoking and outcomes in older adults with atrial fibrillation.
|
Arch Gerontol Geriatr
|
2011
|
0.81
|
|
396
|
Recent US Patterns and Predictors of Prevalent Diabetes among Acute Myocardial Infarction Patients.
|
Cardiol Res Pract
|
2011
|
0.81
|
|
397
|
Relationship between anemia, cardiac troponin I, and B-type natriuretic peptide levels and mortality in patients with advanced heart failure.
|
Am Heart J
|
2005
|
0.81
|
|
398
|
Are we targeting the right metric for heart failure? Comparison of hospital 30-day readmission rates and total episode of care inpatient days.
|
Am Heart J
|
2013
|
0.81
|
|
399
|
Prognostic implications of renal dysfunction in patients hospitalized with heart failure: data from the last decade of clinical investigations.
|
Heart Fail Rev
|
2013
|
0.81
|
|
400
|
Total cholesterol levels and mortality risk in nonischemic systolic heart failure.
|
Am Heart J
|
2006
|
0.81
|
|
401
|
Comparison of composite measure methodologies for rewarding quality of care: an analysis from the American Heart Association's Get With The Guidelines program.
|
Circ Cardiovasc Qual Outcomes
|
2011
|
0.81
|
|
402
|
Reduced right ventricular ejection fraction and increased mortality in chronic systolic heart failure patients receiving β-blockers: insights from the BEST trial.
|
Int J Cardiol
|
2011
|
0.81
|
|
403
|
Use of hydralazine-isosorbide dinitrate combination in African American and other race/ethnic group patients with heart failure and reduced left ventricular ejection fraction.
|
J Am Heart Assoc
|
2013
|
0.81
|
|
404
|
Acute ischemic stroke and timing of treatment--reply.
|
JAMA
|
2013
|
0.81
|
|
405
|
Characteristics and outcomes among heart failure patients with anemia and renal insufficiency with and without blood transfusions (public discharge data from California 2000-2006).
|
Am J Cardiol
|
2011
|
0.81
|
|
406
|
The cardiorenal connection in heart failure.
|
Curr Cardiol Rep
|
2008
|
0.81
|
|
407
|
Antigen carbohydrate 125 and brain natriuretic peptide serial measurements for risk stratification following an episode of acute heart failure.
|
Int J Cardiol
|
2011
|
0.81
|
|
408
|
Epidemiology of hospitalized heart failure: differences and similarities between patients with reduced versus preserved ejection fraction.
|
Heart Fail Clin
|
2013
|
0.81
|
|
409
|
Usefulness of preimplantation B-type natriuretic peptide level for predicting response to cardiac resynchronization therapy.
|
Am J Cardiol
|
2006
|
0.81
|
|
410
|
Relationship between stage of kidney disease and incident heart failure in older adults.
|
Am J Nephrol
|
2011
|
0.81
|
|
411
|
Comparison of direct body composition assessment methods in patients with chronic heart failure.
|
J Card Fail
|
2010
|
0.81
|
|
412
|
Relation among body mass index, exercise training, and outcomes in chronic systolic heart failure.
|
Am J Cardiol
|
2011
|
0.81
|
|
413
|
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.
|
J Am Coll Cardiol
|
2017
|
0.81
|
|
414
|
International variation in use of oral anticoagulation among heart failure patients with atrial fibrillation.
|
Am Heart J
|
2012
|
0.81
|
|
415
|
A propensity-matched study of the comparative effectiveness of angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors in heart failure patients age ≥ 65 years.
|
Am J Cardiol
|
2011
|
0.80
|
|
416
|
Standardizing care for acute decompensated heart failure in a large megatrial: the approach for the Acute Studies of Clinical Effectiveness of Nesiritide in Subjects with Decompensated Heart Failure (ASCEND-HF).
|
Am Heart J
|
2008
|
0.80
|
|
417
|
Influence of coronary angiography on the utilization of therapies in patients with acute heart failure syndromes: findings from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
|
Am Heart J
|
2009
|
0.80
|
|
418
|
Use and predictors of heart failure disease management referral in patients hospitalized with heart failure: insights from the Get With the Guidelines Program.
|
J Card Fail
|
2011
|
0.80
|
|
419
|
Race and improvements in the use of guideline-recommended therapies for patients with heart failure: findings from IMPROVE HF.
|
J Natl Med Assoc
|
2012
|
0.80
|
|
420
|
Do anthropometric indices accurately reflect directly measured body composition in men and women with chronic heart failure?
|
Congest Heart Fail
|
2011
|
0.80
|
|
421
|
Use of renin-angiotensin system blockers in acute coronary syndromes: findings from Get With the Guidelines-Coronary Artery Disease Program.
|
Circ Cardiovasc Qual Outcomes
|
2014
|
0.80
|
|
422
|
An evidence-based score to detect prevalent peripheral artery disease (PAD).
|
Vasc Med
|
2012
|
0.80
|
|
423
|
Early invasive versus initial conservative treatment strategies in octogenarians with UA/NSTEMI.
|
Am J Med
|
2013
|
0.80
|
|
424
|
Effects of enalapril in systolic heart failure patients with and without chronic kidney disease: insights from the SOLVD Treatment trial.
|
Int J Cardiol
|
2012
|
0.80
|
|
425
|
Clinical implications of the obesity paradox in patients with coronary artery disease.
|
Am J Med
|
2009
|
0.80
|
|
426
|
Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association.
|
Circulation
|
2016
|
0.80
|
|
427
|
Recommendations for the Implementation of Telehealth in Cardiovascular and Stroke Care: A Policy Statement From the American Heart Association.
|
Circulation
|
2016
|
0.79
|
|
428
|
Managed care interventions for improving outcomes in acute heart failure syndromes.
|
Am J Manag Care
|
2008
|
0.79
|
|
429
|
Congestion in acute heart failure syndromes: importance of early recognition and treatment.
|
Rev Cardiovasc Med
|
2006
|
0.79
|
|
430
|
Aldosterone antagonists and outcomes in real-world older patients with heart failure and preserved ejection fraction.
|
JACC Heart Fail
|
2013
|
0.79
|
|
431
|
Achievement of guideline-concordant care and in-hospital outcomes in patients with coronary artery disease in teaching and nonteaching hospitals: results from the Get With The Guidelines-Coronary Artery Disease program.
|
Circ Cardiovasc Qual Outcomes
|
2012
|
0.79
|
|
432
|
Regional variation across the United States in management and outcomes of ST-elevation myocardial infarction: analysis of the 2003 to 2010 nationwide inpatient sample database.
|
Clin Cardiol
|
2014
|
0.79
|
|
433
|
Hospital case volume is associated with mortality in patients hospitalized with subarachnoid hemorrhage.
|
Neurosurgery
|
2014
|
0.79
|
|
434
|
Regional hippocampal damage in heart failure.
|
Eur J Heart Fail
|
2015
|
0.79
|
|
435
|
Measures of obesity and outcomes after myocardial infarction.
|
Circulation
|
2008
|
0.79
|
|
436
|
Impact of atrial fibrillation on outcomes in heart failure.
|
Heart Fail Clin
|
2013
|
0.79
|
|
437
|
Giant cell myocarditis in a young man responsive to T-lymphocyte cytolytic therapy.
|
J Heart Lung Transplant
|
2002
|
0.78
|
|
438
|
Global and regional brain mean diffusivity changes in patients with heart failure.
|
J Neurosci Res
|
2014
|
0.78
|
|
439
|
Improving outcomes in post-acute myocardial infarction heart failure: incorporation of aldosterone blockade into combination therapy to optimize neurohormonal blockade.
|
Am J Cardiol
|
2006
|
0.78
|
|
440
|
Cerebral impairment in heart failure.
|
Curr Heart Fail Rep
|
2014
|
0.78
|
|
441
|
Quality of care and outcomes in acute decompensated heart failure: The ADHERE Registry.
|
Curr Heart Fail Rep
|
2004
|
0.78
|
|
442
|
Sources of hospital-level variation in major bleeding among patients with non-st-segment elevation myocardial infarction: a report from the National Cardiovascular Data Registry (NCDR).
|
Circ Cardiovasc Qual Outcomes
|
2014
|
0.78
|
|
443
|
Rapid change in prescribing behavior in hospitals participating in get with the guidelines-stroke after release of the management of atherothrombosis with clopidogrel in high-risk patients (MATCH) clinical trial results.
|
Stroke
|
2010
|
0.78
|
|
444
|
Comprehensive coronary artery disease care in a safety-net hospital: results of Get With The Guidelines quality improvement initiative.
|
J Manag Care Pharm
|
2007
|
0.78
|
|
445
|
Hyponatremia in acute heart failure syndromes: a potential therapeutic target.
|
Curr Heart Fail Rep
|
2007
|
0.78
|
|
446
|
Recognizing hospitalized heart failure as an entity and developing new therapies to improve outcomes: academics', clinicians', industry's, regulators', and payers' perspectives.
|
Heart Fail Clin
|
2013
|
0.78
|
|
447
|
Development and initial testing of the stroke rapid-treatment readiness tool.
|
J Neurosci Nurs
|
2014
|
0.78
|
|
448
|
Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.
|
Clin Cardiol
|
2013
|
0.78
|
|
449
|
Quality of care and outcomes in women hospitalized for heart failure.
|
Circ Heart Fail
|
2011
|
0.78
|
|
450
|
Heart failure management in skilled nursing facilities: a scientific statement from the American Heart Association and the Heart Failure Society of America.
|
J Card Fail
|
2015
|
0.78
|
|
451
|
Intact skeletal muscle mitochondrial enzyme activity but diminished exercise capacity in advanced heart failure patients on optimal medical and device therapy.
|
Clin Res Cardiol
|
2013
|
0.78
|
|
452
|
Site selection for heart failure clinical trials in the USA.
|
Heart Fail Rev
|
2015
|
0.78
|
|
453
|
Role of beta-blocker therapy in the post-myocardial infarction patient with and without left ventricular dysfunction.
|
Rev Cardiovasc Med
|
2003
|
0.78
|
|
454
|
Heart failure is associated with impaired anti-inflammatory and antioxidant properties of high-density lipoproteins.
|
Am J Cardiol
|
2013
|
0.77
|
|
455
|
Comparative effectiveness of diuretic regimens.
|
N Engl J Med
|
2011
|
0.77
|
|
456
|
A point-by-point response to recent arguments against the use of statins in primary prevention: this statement is endorsed by the American Society for Preventive Cardiology.
|
Clin Cardiol
|
2012
|
0.77
|
|
457
|
Lipid profile, lipid-lowering medications, and intracerebral hemorrhage after tPA in get with the guidelines-stroke.
|
Stroke
|
2013
|
0.77
|
|
458
|
Assessment of the quality of existing patient educational tools focused on sudden cardiac arrest: a systematic evaluation by the Sudden Cardiac Arrest Thought Leadership Alliance.
|
Patient Prefer Adherence
|
2013
|
0.77
|
|
459
|
Cardiovascular disease in African Americans. Closing the knowledge, treatment, and outcome gap.
|
Rev Cardiovasc Med
|
2004
|
0.77
|
|
460
|
Relation of serum magnesium levels and postdischarge outcomes in patients hospitalized for heart failure (from the EVEREST Trial).
|
Am J Cardiol
|
2013
|
0.77
|
|
461
|
ACC/AHA 2013 methodology for developing clinical data standards: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards.
|
Circulation
|
2013
|
0.77
|
|
462
|
Support with the BVS 5000 assist device during treatment of acute giant-cell myocarditis.
|
Tex Heart Inst J
|
2003
|
0.77
|
|
463
|
Postdischarge international normalized ratio testing and long-term clinical outcomes of patients with heart failure receiving warfarin: findings from the ADHERE registry linked to Medicare claims.
|
Clin Cardiol
|
2013
|
0.77
|
|
464
|
ACC/AHA/STS Statement on the Future of Registries and the Performance Measurement Enterprise: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and The Society of Thoracic Surgeons.
|
J Am Coll Cardiol
|
2015
|
0.77
|
|
465
|
Addressing disparities in sudden cardiac arrest care and the underutilization of effective therapies.
|
Am Heart J
|
2010
|
0.77
|
|
466
|
[Benefits of statin therapy based on plasma carbohydrate antigen 125 values following an admission for acute heart failure].
|
Rev Esp Cardiol
|
2011
|
0.77
|
|
467
|
ACC/AHA/STS Statement on the Future of Registries and the Performance Measurement Enterprise: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and The Society of Thoracic Surgeons.
|
Ann Thorac Surg
|
2015
|
0.77
|
|
468
|
Age differences in the use of implantable cardioverter-defibrillators among older patients hospitalized with heart failure.
|
J Cardiovasc Electrophysiol
|
2013
|
0.77
|
|
469
|
ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
Circulation
|
2012
|
0.77
|
|
470
|
Quality of care for sudden cardiac arrest: Proposed steps to improve the translation of evidence into practice.
|
Am Heart J
|
2011
|
0.77
|
|
471
|
Factors associated with improvement in guideline-based use of ICDs in eligible heart failure patients.
|
Pacing Clin Electrophysiol
|
2011
|
0.77
|
|
472
|
Beyond coronary sinus angiography: the value of coronary arteriography and identification of the pericardiophrenic vein during left ventricular lead placement.
|
Pacing Clin Electrophysiol
|
2005
|
0.77
|
|
473
|
Clinical profile and prognostic significance of natriuretic peptide trajectory following hospitalization for worsening chronic heart failure: findings from the ASTRONAUT trial.
|
Eur J Heart Fail
|
2015
|
0.76
|
|
474
|
Design and rationale of a retrospective clinical effectiveness study of aldosterone antagonist therapy in patients with heart failure.
|
Am Heart J
|
2012
|
0.76
|
|
475
|
Patient characteristics associated with the choice of triple antithrombotic therapy in acute coronary syndromes.
|
Am J Cardiol
|
2009
|
0.76
|
|
476
|
ACC/AHA/AACVPR/AAFP/ANA concepts for clinician-patient shared accountability in performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.
|
J Am Coll Cardiol
|
2014
|
0.76
|
|
477
|
2015 ACC/AHA Focused Update of Secondary Prevention Lipid Performance Measures: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.
|
Circ Cardiovasc Qual Outcomes
|
2015
|
0.76
|
|
478
|
High-density lipoprotein cholesterol as a therapeutic target to reduce cardiovascular events.
|
Am Heart J
|
2004
|
0.76
|
|
479
|
HDL function as a target of lipid-modifying therapy.
|
Rev Cardiovasc Med
|
2007
|
0.76
|
|
480
|
Clinical effectiveness of anticoagulation therapy among older patients with heart failure and without atrial fibrillation: findings from the ADHERE registry linked to Medicare claims.
|
J Card Fail
|
2013
|
0.76
|
|
481
|
Water and sodium in heart failure: a spotlight on congestion.
|
Heart Fail Rev
|
2015
|
0.76
|
|
482
|
Phase II trials in heart failure: the role of cardiovascular imaging.
|
Am Heart J
|
2011
|
0.76
|
|
483
|
Reperfusion strategies and quality of care in 5339 patients age 80 years or older presenting with ST-elevation myocardial infarction: analysis from get with the guidelines-coronary artery disease.
|
Clin Cardiol
|
2012
|
0.76
|
|
484
|
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.
|
J Card Fail
|
2017
|
0.75
|
|
485
|
2016 AHA/ACC Clinical Performance and Quality Measures for Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.
|
J Am Coll Cardiol
|
2016
|
0.75
|
|
486
|
Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association.
|
Circulation
|
2017
|
0.75
|
|
487
|
Incident heart failure in relation to vascular disease: insights from the Health, Aging, and Body Composition Study.
|
Eur J Heart Fail
|
2014
|
0.75
|
|
488
|
Timing and duration of interventions in clinical trials for patients with hospitalized heart failure.
|
Circ Heart Fail
|
2013
|
0.75
|
|
489
|
Diabetes, quality of care, and in-hospital outcomes in patients hospitalized with heart failure.
|
Am Heart J
|
2011
|
0.75
|
|
490
|
BNP-guided heart failure therapy in older patients.
|
JAMA
|
2009
|
0.75
|
|
491
|
Reply: The AVOID-HF Trial: Points to Consider.
|
JACC Heart Fail
|
2016
|
0.75
|
|
492
|
Association of BNP and Troponin Levels with Outcome among Cardiac Resynchronization Therapy Recipients.
|
Pacing Clin Electrophysiol
|
2015
|
0.75
|
|
493
|
Heart failure: Heart failure clinical trials: how do we define success?
|
Nat Rev Cardiol
|
2013
|
0.75
|
|
494
|
Response to Relationship of race/ethnicity with door-to-balloon time and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: Findings from Get With the Guidelines-Coronary Artery Diseases. Authors' reply.
|
Clin Cardiol
|
2014
|
0.75
|
|
495
|
Reply: To PMID 23219302.
|
J Am Coll Cardiol
|
2013
|
0.75
|
|
496
|
Reply: effect of ivabradine on early readmissions after hospitalization for worsening heart failure.
|
JACC Heart Fail
|
2015
|
0.75
|
|
497
|
REPORT-HF: the unique blend of global heart failure registry and longitudinal cohort study.
|
Eur J Heart Fail
|
2015
|
0.75
|
|
498
|
Reply: To PMID 23273288.
|
J Am Coll Cardiol
|
2013
|
0.75
|
|
499
|
Cerebral blood flow velocity and vasomotor reactivity during autonomic challenges in heart failure.
|
Nurs Res
|
2014
|
0.75
|
|
500
|
Response to letter regarding article, "Four-variable risk model in men and women with heart failure".
|
Circ Heart Fail
|
2014
|
0.75
|
|
501
|
Cholesterol and mortality in heart failure: the bad gone good?
|
J Am Coll Cardiol
|
2003
|
0.75
|
|
502
|
Assessing clinical risk prediction tools.
|
Ann Emerg Med
|
2007
|
0.75
|
|
503
|
The potential application of electrophysiology diagnostics and therapeutics in acute heart failure syndromes.
|
Heart Fail Rev
|
2011
|
0.75
|
|
504
|
Decompensated heart failure: is there a role for the outpatient use of nesiritide?
|
Congest Heart Fail
|
2004
|
0.75
|
|
505
|
Quality of care for patients with acute coronary syndromes as a function of hospital revascularization capability: Insights from get with the guidelines-CAD.
|
Clin Cardiol
|
2014
|
0.75
|
|
506
|
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
|
Circulation
|
2017
|
0.75
|
|
507
|
Acute heart failure syndromes: potential strategies to improve post-discharge outcomes.
|
Curr Treat Options Cardiovasc Med
|
2008
|
0.75
|
|
508
|
The potential role of nonpharmacologic electrophysiology-based interventions in improving outcomes in patients hospitalized for heart failure.
|
Heart Fail Clin
|
2013
|
0.75
|
|
509
|
B-type natriuretic peptide assessment in ambulatory heart failure patients: insights from IMPROVE HF.
|
J Cardiovasc Med (Hagerstown)
|
2012
|
0.75
|
|
510
|
Prevention of heart failure.
|
Curr Cardiol Rep
|
2002
|
0.75
|
|
511
|
Heart failure: wireless hemodynamic monitoring—a new approach for managing HF.
|
Nat Rev Cardiol
|
2011
|
0.75
|
|
512
|
Nutritional supplementation with amino acids in cardiovascular and metabolic diseases: hypermetabolic syndrome as a therapeutic target. Introduction.
|
Am J Cardiol
|
2008
|
0.75
|
|
513
|
Exploring the Potential Benefits and Risks of Anticoagulation for Atrial Fibrillation During Hospitalization for Sepsis.
|
JAMA Cardiol
|
2016
|
0.75
|
|
514
|
Factors associated with improvement in utilization of cardiac resynchronization therapy in eligible heart failure patients: findings from IMPROVE HF.
|
Pacing Clin Electrophysiol
|
2013
|
0.75
|
|
515
|
2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.
|
Circ Cardiovasc Qual Outcomes
|
2017
|
0.75
|
|
516
|
The Art of Health Promotion ideas for improving health outcomes.
|
Am J Health Promot
|
2016
|
0.75
|
|
517
|
Does aspirin use adversely influence intermediate-term postdischarge outcomes for hospitalized patients who are treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers? Findings from Organized Program to Facilitate Life-Saving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
|
Am Heart J
|
2010
|
0.75
|
|
518
|
Lessons learned from recent lipid-lowering trials: why physicians should change clinical practice.
|
Clin Cornerstone
|
2003
|
0.75
|
|
519
|
B-type natriuretic peptide and multimarker approaches in cardiovascular medicine.
|
Rev Cardiovasc Med
|
2003
|
0.75
|
|
520
|
Statins and the Prevention of Heart Disease.
|
JAMA Cardiol
|
2017
|
0.75
|
|
521
|
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
|
Circulation
|
2017
|
0.75
|
|
522
|
Measuring heart failure care by 30-day readmission: Rethinking the quality of outcome measures.
|
Am Heart J
|
2013
|
0.75
|
|
523
|
ACC/AHA/STS Statement on the Future of Registries and the Performance Measurement Enterprise: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and The Society of Thoracic Surgeons.
|
Circ Cardiovasc Qual Outcomes
|
2015
|
0.75
|
|
524
|
Early pharmacological treatment of acute heart failure syndromes: a systematic review of clinical trials.
|
Acute Card Care
|
2007
|
0.75
|
|
525
|
Performance measures to promote quality improvement in sudden cardiac arrest prevention and treatment.
|
Am Heart J
|
2013
|
0.75
|
|
526
|
Weekend/holiday versus weekday hospital discharge and guideline adherence (from the American Heart Association's Get with the Guidelines--Coronary Artery Disease database).
|
Am J Cardiol
|
2008
|
0.75
|
|
527
|
Directions for research in the post-myocardial infarction patient with left ventricular dysfunction.
|
Am J Cardiol
|
2008
|
0.75
|
|
528
|
Prevention of Heart Failure.
|
JAMA Cardiol
|
2016
|
0.75
|
|
529
|
The editor's roundtable: Implantable cardioverter-defibrillators in primary prevention of sudden cardiac death and disparity-related barriers to implementation.
|
Am J Cardiol
|
2011
|
0.75
|
|
530
|
Venous thromboembolism prophylaxis in hospitalized heart failure patients.
|
J Card Fail
|
2008
|
0.75
|
|
531
|
Clinical trials in hospitalized heart failure patients: targeting interventions to optimal phenotypic subpopulations.
|
Heart Fail Rev
|
2015
|
0.75
|
|
532
|
Translating evidence into practice: use of statins in real-world patients with heart failure.
|
Heart Fail Clin
|
2008
|
0.75
|
|
533
|
Progress or lack of progress in hospitalized heart failure.
|
Expert Rev Cardiovasc Ther
|
2013
|
0.75
|
|
534
|
Beta-blocker therapy for heart failure: the standard of care.
|
Rev Cardiovasc Med
|
2002
|
0.75
|
|
535
|
2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.
|
J Am Coll Cardiol
|
2017
|
0.75
|
|
536
|
2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.
|
Circ Cardiovasc Qual Outcomes
|
2016
|
0.75
|
|
537
|
The past, present, and future of statin therapy.
|
Rev Cardiovasc Med
|
2005
|
0.75
|
|
538
|
2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.
|
J Am Coll Cardiol
|
2016
|
0.75
|
|
539
|
Patterns and predictors of discharge statin prescription among hospitalized patients with intracerebral hemorrhage.
|
Stroke
|
2010
|
0.75
|
|
540
|
Noninvasive Bioelectrical Impedance for Predicting Clinical Outcomes in Outpatients With Heart Failure.
|
Crit Pathw Cardiol
|
2017
|
0.75
|
|
541
|
Secondary prevention after coronary bypass: the American Heart Association "Get with the Guidelines" program.
|
Ann Thorac Surg
|
2003
|
0.75
|
|
542
|
Performance achievement award program for Get With The Guidelines--Coronary Artery Disease is associated with global and sustained improvement in cardiac care for patients hospitalized with an acute myocardial infarction.
|
Crit Pathw Cardiol
|
2010
|
0.75
|
|
543
|
The Potential Impact of Expanding Cardiac Rehabilitation in Heart Failure.
|
J Am Coll Cardiol
|
2016
|
0.75
|